Suchergebnisse - "Srivastava, Prashant"

PubPharm (6)

1

Integrative genomics reveals pathogenic mediator of valproate-induced neurodevelopmental disability

enthalten in: Brain : a journal of neurology | 2022

von Feleke, R. | Jazayeri, D. | Abouzeid, M. | +5

CommentIn: Brain. 2022 Oct 12;:. - PMID 36220973

2

Proof-of-concept that network pharmacology is effective to modify development of acquired temporal lobe epilepsy

enthalten in: Neurobiology of disease | 2020

von Schidlitzki, A. | Bascuñana, P. | Srivastava, P. | +14

3

A systems-level framework for drug discovery identifies Csf1R as an anti-epileptic drug target

enthalten in: Nature communications | 2018

von Srivastava, P. | van Eyll, J. | Godard, P. | +23

CommentIn: Epilepsy Curr. 2019 May-Jun;19(3):182-183. - PMID 31035818

4

Genetic variation in CFH predicts phenytoin-induced maculopapular exanthema in European-descent patients

enthalten in: Neurology | 2018

von McCormack, M. | Gui, H. | Ingason, A. | +150

CommentIn: Neurology. 2018 Jan 23;90(4):155-156. - PMID 29288230

5

Carbamazepine- and oxcarbazepine-induced hyponatremia in people with epilepsy

enthalten in: Epilepsia | 2017

von Berghuis, B. | van der Palen, J. | de Haan, G. | +47

6

Rare and common epilepsies converge on a shared gene regulatory network providing opportunities for novel antiepileptic drug discovery

enthalten in: Genome biology | 2016

von Delahaye-Duriez, A. | Srivastava, P. | Shkura, K. | +12

CommentIn: Epilepsy Curr. 2017 Jul-Aug;17 (4):232-234. - PMID 29225529

1
[1]